- Under a premarket approval supplement, the FDA has approved Axonics Modulation Technologies' (NASDAQ:AXNX) new wireless patient Remote Control with SmartMRI technology for the Axonics r-SNM System.
- The new Remote Control simplifies the process by which patients can receive a full-body MRI.
- The new patient Remote Control will be included in all new orders of the Axonics r-SNM System in the U.S. beginning this month.
FDA OKs Axonics' wireless patient remote control with SmartMRI technology
Recommended For You
More Trending News
About AXNX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
AXNX | - | - |
Axonics, Inc. |